相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
A bibliometric analysis of 23,492 publications on rectal cancer by machine learning: basic medical research is needed
Kangtao Wang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Commentary on: Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Francesca De Felice et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
bibliometrix: An R-tool for comprehensive science mapping analysis
Massimo Aria et al.
JOURNAL OF INFORMETRICS (2017)
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis Oxaliplatin in neoadjuvant treatment for rectal cancer
Francesca De Felice et al.
BMC CANCER (2017)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial
Seung-Yong Jeong et al.
LANCET ONCOLOGY (2014)
Neoadjuvant-intensified treatment for rectal cancer: Time to change?
Daniela Musio et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2012)
Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience
Uday B. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Carlo Aschele et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
Mark S. Roh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
Christopher G. Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypcr patients
Carlo Capirci et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
Morten Braendengen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer
JG Guillem et al.
ANNALS OF SURGERY (2005)
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
BM Ghadimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Laparoscopic total mesorectal excision (TME) for rectal cancer surgery - Long-term outcomes
J Leroy et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2004)
Rectal cancer: Review with emphasis on MR imaging
RGH Beets-Tan et al.
RADIOLOGY (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Diffusion MRI for prediction of response of rectal cancer to chemoradiation
A Dzik-Jurasz et al.
LANCET (2002)
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients
V Valentini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival
G Theodoropoulos et al.
DISEASES OF THE COLON & RECTUM (2002)
分享论文
